Mitchell Capital Management Co. Sells 2,202 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Mitchell Capital Management Co. sold 2,202 shares of HCA Healthcare, reducing its holdings by 11.9%, leaving them with 16,268 shares valued at approximately $5.9 million.
• HCA Healthcare reported strong quarterly earnings with $6.84 EPS, surpassing estimates, and achieved a revenue of $18.61 billion, up 6.4% year-over-year.
• A recent analyst rating update indicates a consensus rating of "Moderate Buy" for HCA Healthcare, with target prices ranging from $401 to $465, reflecting strong interest among institutional investors.

Mitchell Capital Management Co. lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,268 shares of the company's stock after selling 2,202 shares during the period. HCA Healthcare makes up about 1.1% of Mitchell Capital Management Co.'s investment portfolio, making the stock its 24th largest position. Mitchell Capital Management Co.'s holdings in HCA Healthcare were worth $5,875,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Chung Wu Investment Group LLC bought a new position in HCA Healthcare during the second quarter valued at $27,000. Ameriflex Group Inc. bought a new position in HCA Healthcare during the second quarter valued at $27,000. Cheviot Value Management LLC bought a new position in HCA Healthcare during the first quarter valued at $26,000. Saudi Central Bank bought a new position in HCA Healthcare during the first quarter valued at $26,000. Finally, WPG Advisers LLC bought a new position in HCA Healthcare during the first quarter valued at $27,000. Institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HCA. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada lowered their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Bank of America boosted their target price on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a research note on Wednesday, September 10th. KeyCorp boosted their target price on shares of HCA Healthcare from $370.00 to $465.00 and gave the company an "overweight" rating in a research note on Wednesday. Finally, Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $422.31.

HCA Healthcare Price Performance

NYSE:HCA opened at $414.73 on Monday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $439.01. The company has a 50-day moving average of $405.12 and a 200 day moving average of $376.08. The firm has a market cap of $97.04 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.